F. Sapienza

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

R. Griffiths, J. Henningfield, C. Nichols, 2022, Neuropharmacology.

Abuse deterrent formulations and the Controlled Substances Act (CSA).

F. Sapienza, 2006, Drug and alcohol dependence.

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

T. Kosten, J. Henningfield, A. Mattarei, 2023, Translational psychiatry.